BRAIDWELL LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
BRAIDWELL LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$40,943,996
-4.8%
65,976,0000.0%1.29%
-8.0%
Q2 2023$43,016,352
-15.9%
65,976,0000.0%1.41%
-16.7%
Q1 2023$51,148,346
+3.6%
65,976,0000.0%1.69%
+2.0%
Q4 2022$49,369,84165,976,0001.65%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birch Grove Capital LP 9,000,000$6,561,0002.60%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 31,050,000$22,600,0000.52%
Context Capital Management, LLC 7,000$5,079,0000.36%
DeepCurrents Investment Group LLC 11,890,000$8,569,0000.34%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 25,000,000$18,139,0000.31%
CAPSTONE INVESTMENT ADVISORS, LLC 5,500,000$4,046,0000.02%
LAZARD ASSET MANAGEMENT LLC 17,500,000$12,872,0000.02%
BLB&B Advisors, LLC 100,000$73,0000.01%
MACKAY SHIELDS LLC 221,000$163,0000.00%
JPMORGAN CHASE & CO 900,000$655,0000.00%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders